today announced a fresh strategic concentrate on its rewarding pharmaceutical contract production business, PharmaForm, LLC ., Ltd. , and the initiation of bankruptcy proceedings for the Company’s Finnish subsidiary. Corporate concentrate on PharmaForm Division Investing in capacity expansion Access into Continue reading Akela announces new corporate focus on PharmaForm Akela Pharma.→